Start for free
Start for free
EC

EGB Capital

North America, California, United States, Los Angeles

Description

EGB Capital is an investment firm.

Investor Profile

EGB Capital has made 5 investments, with 2 in the past 12 months and 20% as lead.

Stage Focus

  • Series A (40%)
  • Seed (40%)
  • Pre Seed (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Genetics
  • Medical
  • Software
  • Life Science
  • Medical Device
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does EGB Capital frequently co-invest with?

Elm Street Ventures
Elm Street Ventures
North America, Connecticut, United States, New Haven
Co-Investments: 1
Embark Ventures
Embark Ventures
North America, California, United States, Los Angeles
Co-Investments: 2
Bee Partners
Bee Partners
North America, California, United States, San Francisco
Co-Investments: 1
Dynamk Capital
Dynamk Capital
North America, New York, United States, New York
Co-Investments: 1
Courtyard Ventures
Courtyard Ventures
North America, California, United States, Berkeley
Co-Investments: 2
Riverine Ventures
Riverine Ventures
North America, California, United States, Sausalito
Co-Investments: 1
Cota Capital
Cota Capital
North America, California, United States, San Francisco
Co-Investments: 1
GreatPoint Ventures
GreatPoint Ventures
North America, Michigan, United States, New Haven
Co-Investments: 1
M Ventures
M Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Khosla Ventures
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by EGB Capital?

MiLaboratories

Sunnyvale, California, United States

MiLaboratories is a biotech company developing leading software platform for immune repertoire profiling

BiotechnologyGeneticsSoftware
Series AOct 10, 2024
Amount Raised: $10,000,000
SyntaxBio

Chicago, Illinois, United States

SyntaxBio develops genetic programming platform that can program cells without the need for consistent external intervention.

BiotechnologyMedicalProduct Research
SeedSep 17, 2024
Izote Biosciences

Berkeley, California, United States

Biomanufacturing Scale-Up Solution

BiotechnologyGeneticsLife Science
Pre SeedFeb 1, 2024
Amount Raised: $2,600,000
CellFE

Alameda, California, United States

CellFE is a company developing a microfluidics based device to deliver gene-editing molecules.

BiotechnologyHealth Care
Series ASep 27, 2023
Amount Raised: $22,000,000
C. Light Technologies

Berkeley, California, United States

C. Light Technologies is a developer of a retinal eye-tracking platform used to improve the monitoring of neurodegenerative diseases.

Health CareMedicalMedical DeviceSoftware
SeedFeb 2, 2021
Amount Raised: $4,100,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator